A narrative review on the management of Acute Heart Failure in Emergency Medicine Department

Submitted: 8 October 2019
Accepted: 8 November 2019
Published: 1 April 2020
Abstract Views: 1309
PDF: 808
HTML: 12
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

The main urgent symptom presented to anemergency departmentis acute heart failure (AHF). In that considerable risksof morbidity and mortality, it isimportant to plan precision medicine to achieve the most suitable outcomes. The object of this review is to provide a summary of contemporary management proceduresof emergency medicine in a department of acute heart failure. Heart failure could be presented with a broad range of symptoms, in particular a sudden worsening of those of Chronic Obstructive Pulmonary Disease. The treatment should focus on acute and chronic underlying disorders with instructions focusing on haemodynamics and blood pressure status. Treatment of patients suffering with worsening symptoms of AHF mainly focuses on intravenous diuretics. In emergency situations, patients suffering with AHF with low blood pressure must receive emergency consultation and a primary fluid bolus therapy (range 250–500 mL) followed by inotropic therapy with or without antihypotensive agents. For treatment of severe heart failure and cardiogenic shock in patients treated with noradrenalin, when blood pressure support is required, a direct-acting inotropic agent, dobutamine, could be applied effectively. When non-invasive positive pressure ventilation is needed, suppliers must track for any possibility of sudden worsening, i.e., for acute de compensated heart failure. When cardiac output is high the disorder could be treated with vasopressor.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Kamilė C, Tuija J, Raphaël C, et al. 2018. Acute Heart Failure Management. Korean Circ J. 48(6): 463–480.
Pang PS, Schuur JD. 2014. Emergency departments, acute heart failure, and admissions: one size does not fit all. JACC Heart failure.2(3):278-280.
Gang L, Bryan L. S, Flory L. N, et al. 2019. Predicting Appropriate Hospital Admission of Emergency Department Patients with Bronchiolitis: Secondary Analysis. JMIR Med Inform. 7(1): e12591.
Schrager J, Wheatley M, Georgiopoulou V, et al. 2013. Favorable bed utilization and readmission rates for emergency department observation unit heart failure patients. Acad Emerg Med; 20:554-61.
Yancy C. W, Jessup M, et al. 2013. ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation;128: e240-327.
Dick C. K, Frank P. 2015. Diagnosing and managing acute heart failure in the emergency department. Clin Exp Emerg Med;2(3):141-149.
Pang PS, Zaman M. 2013. Airway Management & Assessment of Dyspnea in Emergency Department Patients with Acute Heart Failure. Current emergency and hospital medicine reports. 1(2):122-125.
Rochwerg B, Brochard L, Elliott MW, et al. 2017. Ofcial ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J; 50:1602426.
Salah K, Kok WE, Eurlings LW, et al. 2014. A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: A European coLlaboration on Acute decompeNsated Heart Failure: ELANHF Score. Heart (British Cardiac Society) 100:115–125
Wong YW, Fonarow GC, Mi X, et al. 2013. Early intravenous heart failure therapy and outcomes among older patients hospitalized for acute decompensated heart failure: findings from the Acute Decompensated Heart Failure Registry Emergency Module (ADHERE-EM). Am Heart J.166(2):349-356.
Martindale JL. 2016. Resolution of sonographic B-lines as a measure of pulmonary decongestion in acute heart failure. Am J Emerg Med. 34(6):1129-1132.
Zhipeng C, Yuqing J, Baoli Z. 2019. BNP and NT-proBNP as Diagnostic Biomarkers for Cardiac Dysfunction in Both Clinical and Forensic Medicine. Int. J. Mol. Sci. 20, 1820; doi:10.3390/ijms20081820.
Christ M, Mueller C. 2015. Call to action: initiation of multidisciplinary care for acute heart failure begins in the emergency department. Eur Heart J Acute Cardiovasc Care. doi: 10.1177/2048872615581501.
Nithianandan H, Reilly A, Wells P. 2019. Regarding the necessity of an updated meta-analysis on the prognostic value of serum biomarkers in patients with pulmonary embolism. Thromb Res. 176:8-10. doi: 10.1016/j.thromres.2019.02.005.
Alberto P, Gaetano R, Behar C, et al. 2015. Combined BNP and Echocardiographic assessment in interstitial lung disease for pulmonary hypertension detection.
Frederique E. P, Bas L K, Judith H, et al. 2019. Biological variation of cardiac markers in patients with aortic valve stenosis. Open Heart. 6(1): e001040.
Braga JR, Tu JV, Austin PC, et al. 2013. Outcomes and care of patients with acute heart failure syndromes and cardiac troponin elevation. Circulation Heart failure. 6(2):193-202.
James L. J, Gerasimos F, Markku N, et al. 2012. Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section. European Heart Journal, Volume 33, Issue 18, Pages 2265–2271.
Ponikowski P, Voors AA, Anker SD, et al. 2016. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 18(8):891-975.
Frances M. R, Peter S. P. 2018. Acute Heart Failure Risk Stratification in the Emergency Department: Are We There Yet? Rev Esp Cardiol. 72(3):190–191.
Bakosis G, Christofilis I, Karavidas A. 2017. Treatment goals and discharge criteria for hospitalized patients with acute heart failure. Continuing Cardiology Education, 3(3), https://doi.org/10.1002/cce2.58.
Unluer E. E, Karagoz A, Akoglu H, et al. 2014. Visual estimation of bedside echocardiographic ejection fraction by emergency physicians. West J Emerg Med. 15(2):221-226.
Susanna P, Elke P, Louise C, et al. 2017. Echocardiography and lung ultrasonography for the assessment and management of acute heart failure. Nature Reviews Cardiology volume 14, pages 427–440.
Dimitrios F, John P, John L, et al. 2015. Acute Heart Failure: Epidemiology, Risk Factors, and Prevention. Rev Esp Cardiol. 68(3) :245–248.
Benton R. H, Jennifer M, Osama A, et al. 2017. Approach to Acute Heart Failure in the Emergency Department. Cardiovascular Diseases, doi: 10.1016/j.pcad.2017.08.008.
Pang PS, Collins SP, Miro O, et al. 2015. The role of the emergency department in the management of acute heart failure: An international perspective on education and research. Eur Heart J Acute Cardiovasc Care.
Pierpaolo P, Kuldeep K, Andrew L. C. 2015. Fluid Management in Patients with Chronic Heart Failure. Card Fail Rev. 1(2): 90–95.
Fallick C, Sobotka PA, Dunlap ME. 2011. Sympathetically mediated changes in capacitance: redistribution of the venous reservoir as a cause of decompensation. Circulation Heart failure. 4(5):669-675.
Carson PE, Anand IS, Win S, et al. 2015. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction). JACC Heart Fail. 3:429–441.
Tsuyoshi S, Atsushi S, Shoji H, et al. 2019. Clinical characteristics of hospitalized heart failure patients with preserved, mid‐range, and reduced ejection fractions in Japan. ESC Heart Fail. 6(3): 475–486.
Lam CS, Borlaug BA, Kane GC, et al. 2009. Age‐associated increases in pulmonary artery systolic pressure in the general population. Circulation; 119: 2663–2670.
Mebazaa A, Yilmaz MB, Levy P, et al. 2015. Recommendations on pre-hospital & early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine. Eur J Heart Fail; 17:544-58.
Mebazaa A, Motiejunaite J, Gayat E, et al. 2018. Long-term safety of intravenous cardiovascular agents in acute heart failure: results from the European Society of Cardiology Heart Failure Long-Term Registry. Eur J Heart Fail; 20:332-41.
Baris Afsar, Alberto Ortiz, Adrian Covic, et al. 2016. Focus on renal congestion in heart failure. Clinical Kidney Journal, Volume 9, Issue 1, Pages 39–47.
De Backer D, Biston P, Devriendt J, et al. 2010. Comparison of dopamine and norepinephrine in the treatment of shock. The New England journal of medicine.362(9):779-789.
Yancy CW, Jessup M, Bozkurt B, et al. 2013. 2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation.
Fermín L, Hector R. C, Christian C. L, et al. 2019. Treatment of Hypertensive Cardiogenic Edema with Intravenous High-Dose Nitroglycerin in a Patient Presenting with Signs of Respiratory Failure: A Case Report and Review of the Literature. Am J Case Rep. 20: 83–90.
Salvatore D. S, Laura M. 2015. Drug Therapy for Acute Heart Failure. Rev Esp Cardiol. 68(8) :706–713.
Emelia J. B, Paul M, Alvaro A, et al. 2019. Heart Disease and Stroke Statistics—2019 Update: A Report from the American Heart Association. Circulation.;139: e56–e528. DOI: 10.1161/CIR.0000000000000659.
Sam L. T, Alan S. M, Alan B. S. 2015. Challenges in Acute Heart Failure Clinical Management: Optimizing Care Despite Incomplete Evidence and Imperfect Drugs. Crit Pathw Cardiol. 14(1): 12–24.
Neal L. W, Sean P. C, Peter S. P, et al. 2010. AHA Scientific StatementAcute Heart Failure Syndromes: Emergency DepartmentPresentation, Treatment, and Disposition: CurrentApproaches and Future Aims. Circulation.122:1975–1996.
Storrow A, Jenkins C, Self WH, et al. 2014. The Burden of Acute Heart Failure on US Emergency Departments. Journal of The American College of Cardiology: Heart Failure.
Sean P. C, Peter S. P. 2019. ACUTE Heart Failure Risk Stratification. Circulation.;139:1157–1161.
Lee D. S, Ezekowitz J. A. 2014. Risk stratification in acute heart failure. Can J Cardiol. 30(3):312-9.
Hsiao J, Motta M, Wyer P. 2012. Validating the acute heart failure index for patients presenting to the emergency department with decompensated heart failure. Emerg Med J. 29(12): e5.
Peter S. P, Gregory J. F, Benton R. H, et al. 2019. TACIT (High Sensitivity Troponin T Rules Out Acute Cardiac Insufficiency Trial). Circ Heart Fail. 12(7): e005931. doi: 10.1161/CIRCHEARTFAILURE.119.005931.
Shawna D. B, Merri L. B, Stephen L. K, et al. 2016. Impact of an Emergency Department Observation Unit Management Algorithm for Atrial Fibrillation. J Am Heart Assoc. 5: e002984 doi: 10.1161/JAHA.115.002984.
Ibanez B, James S, Agewall S, et al. 2017. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 39 (2), 119–177.
Evandro T. M, Antonio J, L. J, Luciana M. R, et al. 2017. Understanding Hospitalization in Patients with Heart Failure. Int J Cardiovasc Sci 30(1):81-90.

How to Cite

Saberinia, A., Vafaei, A., & Kashani, P. (2020). A narrative review on the management of Acute Heart Failure in Emergency Medicine Department. European Journal of Translational Myology, 30(1), 171–178. https://doi.org/10.4081/ejtm.2019.8612

Similar Articles

You may also start an advanced similarity search for this article.